Live Quote · NASDAQEYENHealthcare· Biotechnology

Eyenovia, Inc.

$7.56 3.99%(+$0.29)
TickerSpark Score
64/100
Mixed
53
Valuation
40
Profitability
100
Growth
76
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EYEN research report →

52-Week Range5% of range
Low
$0.85
Current
$7.56
High
$124.80
Company Overviewwww.eyenovia.com

About the company

Eyenovia, Inc. , a New York-based company established in 2014 (originally incorporated as PGP Holdings V, Inc. ), functions as a clinical-stage pharmaceutical firm specializing in ophthalmology.

CEO
Michael M. Rowe
IPO
2018
Employees
13
HQ
New York City, NY, US

Price Chart

-89.56% · this period
$41.45$21.19$0.92Nov 01May 07Nov 17
Valuation
Market Cap
$38.59M
P/E
-0.22
P/S
14.88
P/B
0.56
EV/EBITDA
-0.54
Div Yield
0.00%
Profitability
Gross Margin
63.68%
Op Margin
-2012.57%
Net Margin
-3163.01%
ROE
-63.54%
ROIC
-31.07%
Growth & Income
Revenue
$813.46K · 1318.75%
Net Income
$-45,314,435 · 9.04%
EPS
$-9.40 · 84.28%
Op Income
$-18,981,294
FCF YoY
-48674.69%
Performance & Tape
52W High
$124.80
52W Low
$0.85
50D MA
$4.53
200D MA
$9.74
Beta
1.00
Avg Volume
4.65M

Get TickerSpark's AI analysis on EYEN

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Feb 21, 25Avenue Capital Management II, L.P.other5,952,381
Jan 31, 25Avenue Capital Management II, L.P.other0
Nov 22, 22Avenue Capital Management II, L.P.other2,327,747
Apr 21, 25Strahlman Ellen Rother3,000
Apr 21, 25Palanki Ramother3,000
Apr 21, 25MATHER CHARLES E IVother8,000
Apr 21, 25JACOBSON RACHELother3,000
Apr 21, 25Ianchulev Tsontchoother5,000
Apr 21, 25GELTZEILER MICHAEL Sother5,000
Apr 21, 25Strahlman Ellen Rother3,000
Coverage · EYEN

Our EYEN coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on EYEN yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate EYEN report →
Internal Compare

Similar companies

Peers in the same neighborhood.